Alectinib Hydrochloride Patent Expiration
Alectinib Hydrochloride was first introduced by Hoffmann-La Roche Inc
Alectinib Hydrochloride Patents
Given below is the list of patents protecting Alectinib Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Alecensa | US10350214 | Preparation containing tetracyclic compound at high dose | Apr 24, 2035 | Hoffmann-la Roche |
| Alecensa | US11433076 | Preparation containing tetracyclic compound at high dose | Apr 24, 2035 | Hoffmann-la Roche |
| Alecensa | US9365514 | Composition comprising tetracyclic compound | Mar 04, 2032 | Hoffmann-la Roche |
| Alecensa | US9126931 | Tetracyclic compound | May 29, 2031 | Hoffmann-la Roche |
| Alecensa | US9440922 | Tetracyclic compound | Jun 09, 2030 | Hoffmann-la Roche |
Alectinib Hydrochloride's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List